| Nanocarrier‐hydrogel composite delivery systems for precision drug release LE Kass, J Nguyen Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, e1756, 2021 | 93 | 2021 |
| Composite double network hydrogels with thermoresponsive colloidal nanoemulsions L Kass, ED Cardenas‐Vasquez, LC Hsiao AIChE Journal 65 (12), e16817, 2019 | 14 | 2019 |
| Use of FLOSEAL® as a Scaffold and its Impact on Induced Neural Stem Cell Phenotype, Persistence, and Efficacy HN Bomba, A Carey‐Ewend, KT Sheets, A Valdivia, M Goetz, IA Findlay, ... Bioengineering & Translational Medicine, e10283, 0 | 13 | |
| Development of a biocompatible 3D hydrogel scaffold using continuous liquid interface production for the delivery of cell therapies to treat recurrent glioblastoma L Kass, M Thang, Y Zhang, C DeVane, J Logan, A Tessema, J Perry, ... Bioengineering & Translational Medicine, e10676, 2024 | 2 | 2024 |
| Combining the constitutive TRAIL-secreting induced neural stem cell therapy with the novel anti-cancer drug TR-107 in glioblastoma M Thang, C Mellows, LE Kass, S Daglish, EMJ Fennell, BE Mann, ... Molecular Therapy Oncology 32 (3), 2024 | 1 | 2024 |
| Combining the constitutive TRAIL-secreting induced neural stem cell therapy with the novel anti-cancer drug TR-107 in glioblastoma M Thang, C Mellows, LE Kass, S Daglish, EMJ Fennell, BE Mann, ... Molecular Therapy Oncology 32 (3), 2024 | | 2024 |
| Use of Continuous Liquid Interface Production (CLIP) to Develop Rationally Designed 3D Scaffolds to Deliver Therapeutic Neural Stem Cells for the Treatment of Glioblastoma LE Kass The University of North Carolina at Chapel Hill, 2024 | | 2024 |
| EXTH-13. ENHANCING INDUCED NEURAL STEM CELL-BASED TRAIL THERAPY FOR GLIOBLASTOMA THROUGH COMBINATION WITH THE NOVEL SENSITIZING AGENT TR-107 M Thang, C Mellows, B Mann, L Kass, S Daglish, E Fennell, ... Neuro-Oncology 25 (Suppl 5), v226, 2023 | | 2023 |
| ENHANCING INDUCED NEURAL STEM CELL-BASED TRAIL THERAPY FOR GLIOBLASTOMA THROUGH COMBINATION WITH THE NOVEL SENSITIZING AGENT TR-107 M Thang, C Mellows, B Mann, L Kass, S Daglish, E Fennell, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |
| EXTH-35. INCREASING THERAPEUTIC INDUCED NEURAL STEM CELL PERSISTENCE IN THE GLIOBLASTOMA TUMOR RESECTION CAVITY H Bomba, L Kass, K Sheets, A Carey-Ewend, M Goetz, J Bago, S Khagi, ... Neuro-Oncology 23 (Suppl 6), vi171, 2021 | | 2021 |
| DDEL-04. BIOMATERIAL SCAFFOLDS FOR THE DELIVERY OF NEURAL STEM CELL THERAPIES INTO THE GLIOBLASTOMA RESECTION CAVITY HN Bomba, L Kass, AG Carey-Ewend, S Hingtgen Education 2015, 2011 | | 2011 |